Javascript must be enabled to continue!
What Is the Evidence to Support Ongoing Nasogastric Tube Position Testing? A Prospective Observational Study of Adverse Events in Australia and the United Kingdom
View through CrossRef
ABSTRACTBackgroundOngoing nasogastric tube (NGT) testing guidelines aim to prevent the use of a displaced NGT; however, guidelines vary, and the relative risks and benefits of different testing methods are unknown.AimTo observe methods used in two hospitals to confirm ongoing NGT position and any differences in outcomes.MethodsData were collected prospectively from the medical records of 256 patients with NGTs across a London National Health Service Trust and a Brisbane hospital. These hospitals use different methods of ongoing NGT position confirmation, predominantly pH tests and external tube length measurement (ETLM), respectively. Statistical models explored outcomes associated with test results, including confirmation of NGT position, number of X‐rays, and delivery of enteral nutrition and medication.ResultsMost ongoing NGT position tests in London were pH (83.4%) and in Brisbane were ETLM (98.6%). Overall, eight NGTs were reported as displaced, of which six were identified by oral cavity inspection. One hundred and eighty‐five (31.8%) ongoing pH tests failed to confirm that the NGT remained correctly positioned. Failed ongoing NGT position tests were associated with significantly more X‐rays, which resulted in disruptions to enteral nutrition and medications in London (n = 64, 47.1%) compared to Brisbane (n = 9, 7.5%) (p < 0.001).Linking Evidence to ActionOverall, NGT displacement occurred rarely. Compared to ETLM, pH tests frequently failed to confirm that the tube remained correctly positioned, resulting in X‐rays and disruptions to enteral nutrition and medications. Oral cavity inspection alongside ETLM could be a safe alternative method to pH testing but requires more research to examine generalizability.
Title: What Is the Evidence to Support Ongoing Nasogastric Tube Position Testing? A Prospective Observational Study of Adverse Events in Australia and the United Kingdom
Description:
ABSTRACTBackgroundOngoing nasogastric tube (NGT) testing guidelines aim to prevent the use of a displaced NGT; however, guidelines vary, and the relative risks and benefits of different testing methods are unknown.
AimTo observe methods used in two hospitals to confirm ongoing NGT position and any differences in outcomes.
MethodsData were collected prospectively from the medical records of 256 patients with NGTs across a London National Health Service Trust and a Brisbane hospital.
These hospitals use different methods of ongoing NGT position confirmation, predominantly pH tests and external tube length measurement (ETLM), respectively.
Statistical models explored outcomes associated with test results, including confirmation of NGT position, number of X‐rays, and delivery of enteral nutrition and medication.
ResultsMost ongoing NGT position tests in London were pH (83.
4%) and in Brisbane were ETLM (98.
6%).
Overall, eight NGTs were reported as displaced, of which six were identified by oral cavity inspection.
One hundred and eighty‐five (31.
8%) ongoing pH tests failed to confirm that the NGT remained correctly positioned.
Failed ongoing NGT position tests were associated with significantly more X‐rays, which resulted in disruptions to enteral nutrition and medications in London (n = 64, 47.
1%) compared to Brisbane (n = 9, 7.
5%) (p < 0.
001).
Linking Evidence to ActionOverall, NGT displacement occurred rarely.
Compared to ETLM, pH tests frequently failed to confirm that the tube remained correctly positioned, resulting in X‐rays and disruptions to enteral nutrition and medications.
Oral cavity inspection alongside ETLM could be a safe alternative method to pH testing but requires more research to examine generalizability.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
GEOINFORMATION FOR DISASTER MANAGEMENT 2020 (GI4DM2020): PREFACE
GEOINFORMATION FOR DISASTER MANAGEMENT 2020 (GI4DM2020): PREFACE
Abstract. Across the world, nature-triggered disasters fuelled by climate change are worsening. Some two billion people have been affected by the consequences of natural hazards ov...
An improved biologically transparent illumination system that increases the accuracy of detecting the correct position of a nasogastric tube in the stomach
An improved biologically transparent illumination system that increases the accuracy of detecting the correct position of a nasogastric tube in the stomach
The aim of this study was to determine whether an improved biologically transparent illumination system results in more reliable detection of the correct position of the nasogastri...

